Publisher： John Wiley & Sons Inc
E-ISSN： 1099-1069|36|1|320-323
ISSN： 0278-0232
Source： Hematological Oncology (Electronic), Vol.36, Iss.1, 2018-02, pp. : 320-323
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Cyclosporin `may be a therapeutic option' in patients with refractory coeliac disease
Inpharma, Vol. 1, Iss. 1248, 2000-01 ,pp. :
Access to resources
Recommend
Is tocilizumab an option for the treatment of arthritis?
Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 11, 2008-08 ,pp. :
Tocilizumab an exciting OPTION in rheumatoid arthritis
Inpharma, Vol. 1, Iss. 1597, 2007-01 ,pp. :
Therapeutic Potential in Alzheimer Disease
Current Medicinal Chemistry, Vol. 9, Iss. 17, 2002-09 ,pp. :